Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion

Blood

Volumn 101, Issue 8, 2003, Pages 3281-3287

  Hines, Patrick C ^b   Zen, Qin ^b   Burney, Sharran N ^b   Shea, Deborah A ^b   Ataga, Kenneth I ^b   Orringer, Eugene P ^b   Telen, Marilyn J ^b   Parise, Leslie V ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CELL ADHESION MOLECULE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; LAMININ; LAMININ RECEPTOR; RECOMBINANT PROTEIN; ISOPROTEIN; LAMININ 10; LAMININ 11 PROTEIN, HUMAN; LU PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; BASAL CELL; BLOOD GROUP LUTHERAN SYSTEM; CELL ADHESION; CELL DENSITY; CELL POPULATION; CONTROLLED STUDY; ERYTHROCYTE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SICKLE CELL; SICKLE CELL ANEMIA; SIGNAL TRANSDUCTION; STRESS; BLOOD; BLOOD CELL COUNT; CLASSIFICATION; CYTOLOGY; DRUG EFFECT; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DISORDER; METABOLISM; PHYSIOLOGY; RETICULOCYTE; SECOND MESSENGER;

ANEMIA, SICKLE CELL; BLOOD CELL COUNT; CELL ADHESION; CELL ADHESION MOLECULES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPINEPHRINE; ERYTHROCYTE AGGREGATION; ERYTHROCYTES, ABNORMAL; FORSKOLIN; HUMANS; LAMININ; NEOPLASM PROTEINS; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, BETA-2; RECOMBINANT PROTEINS; RETICULOCYTES; SECOND MESSENGER SYSTEMS;

EID: 0037606006     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-12-0289     Document Type: Article

References (36)

1. Kikkawa Y, Sanzen N, Sekiguchi K. Isolation and characterization of laminin-10/11 secreted by human lung carcinoma cells. Laminin-10/11 mediates cell adhesion through integrin alpha3 beta1. J Biol Chem. 1998;273:15854-15859.
2. Lee SP, Cunningham ML, Hines PC, Joneckis CC, Orringer EP, Parise LV. Sickle cell adhesion to laminin: potential role for the alpha5 chain. Blood. 1998;92:2951-2958.
3. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337:1584-1590.
4. Boladn DM, Swerdlow P, Wallace AM, Littsey L. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease. Haematologia (Budap). 1998;29:51-58.
5. Udani M, Zen Q, Cottman M, et al. Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest. 1998;101:2550-2558.
6. Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal trasduction. J Clin Invest. 2001;107:1555-1562.
7. Minetti G, Low PS. Erythrocyte signal transduction pathways and their possible functions. Curr Opin Hematol. 1997;4:116-121.
8. Oonishi T, Sakashita K, Uyesaka N. Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways. Am J Physiol. 1997;273:C1828-C1834.
9. Tuvia S, Moses A, Gulayev N, Levin S, Korenstein R. Beta-adrenergic agonists regulate cell membrane fluctuations of human erythrocytes. J Physiol. 1999;516(Pt 3):781-792.
10. Gilman AG. G proteins: transducers of receptor-generated signals. Annu Rev Biochem. 1987;56:615-649.
11. Walter U, Eigenthaler M, Geiger J, Reinhard M. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol. 1993;344:237-249.
12. Queen LR, Xu B, Horinouchi K, Fisher I, Ferro A. β(2)-adrenoceptors activate nitric oxide synthase in human platelets. Circ Res. 2000;87:39-44.
13. Saeed SA, Javed MH, Ashraf G. Modulation of cyclic AMP-dependent protein kinase activity by drugs affecting human platelet aggregation. Biochem Soc Trans. 1993;21:430S.
14. Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs. 2001;10:865-890.
15. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol. 1999;26:74-84.
16. Liao CH, Tzeng CC, Teng CM. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)-quinol inone (CCT-62). Eur J Pharmacol. 1998;349:107-114.
17. Rovere P, Inverardi L, Bender JR, Pardi R. Feedback modulation of ligand-engaged alpha L/β2 leukocyte integdn (LFA-1) by cyclic AMP-dependent protein kinase. J Immunol. 1996;156:2273-2279.
18. Laudanna C, Campbell JJ, Butcher EC. Elevation of intracellular cAMP inhibits RhoA activation and integrin-dependent leukocyte adhesion induced by chemoattractants. J Biol Chem. 1997;272:24141-24144.
19. Wang J, Brown EJ. Immune complex-induced integrin activation and L-plastin phosphorylation require protein kinase A. J Biol Chem. 1999;274:24349-24356.
20. Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol. 1999;162:4285-4292.
21. Barabino G, McIntire L, Eskin S, Sears D, Udden M. Endothelial cell interactions with sickle cell, sickle cell trait, mechanically injured and normal erythrocytes under controlled flow. Blood. 1987;70:152-157.
22. Joneckis CC, Shock DD, Cunningham ML, Orringer EP, Parise LV. Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions. Blood. 1996;87:4862-4870.
23. Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood. 1996;87:4879-4886.
24. Bookchin RM, Lew VL. Pathophysiology of sickle cell anemia. Hematol Oncol Clin North Am. 1996;10:1241-1253.
25. Levitzki A. From epinephrine to cyclic AMP. Science. 1988;241:800-806.
26. Marques F, Bicho MP. Activation of a NADH dehydrogenase in the human erythrocyte by beta-adrenergic agonists: possible involvement of a G protein in enzyme activation. Biol Signals. 1997;6:52-61.
27. Aurbach GD, Spiegel AM, Gardner JD. Beta-adrenergic receptors, cyclic AMP, and ion transport in the avian erythrocyte. Adv Cyclic Nucleotide Res. 1975;5:117-132.
28. Horga JF, Gisbert J, De Agustin JC, Hernandez M, Zapater P. A beta-2-adrenergic receptor activates adenylate cyclase in human erythrocyte membranes at physiological calcium plasma concentrations. Blood Cells Mol Dis. 2000;26:223-228.
29. Zen Q 0, Cottman M, Truskey G, Fraser R, Telen MJ. Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin. J Biol Chem. 1999;274:728-734.
30. Schoenwaelder SM, Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr Opin Cell Biol. 1999;11:274-286.
31. Cartron JP. Defining the Rh blood group antigens. Biochemistry and molecular genetics. Blood Rev. 1994;8:199-212.
32. Charache S, Conley CL, Waugh DF, Ugoretz RJ, Spurrell JR. Pathogenesis of hemolytic anemia in homozygous hemoglobin C disease. J Clin Invest. 1967;46:1795-1811.
33. Whittard JD, Akiyama SK. Positive regulation of cell-cell and cell-substrate adhesion by protein kinase A. J Cell Sci. 2001;114:3265-3272.
34. Larner AC, Ross EM. Alteration in the protein components of catecholamine-sensitive adenylate cyclase during maturation of rat reticulocytes. J Biol Chem. 1981;256:9551-9557.
35. Gil KM, Carson JW, Sedway JA, Porter LS, Schaeffer JJ, Orringer E. Follow-up of coping skills training in adults with sickle cell disease: analysis of daily pain and coping practice diaries. Health. 2000;19:85-90.
36. Thompson RJ Jr, Gil KM, Abrams MR, Phillips G. Psychological adjustment of adults with sickle cell anemia: stability over 20 months, correlates, and predictors. J Clin Psychol. 1996;52:253-261.